Over the past 12 months, 0 insiders at vTv Therapeutics Inc. filed 0 open-market SEC Form 4 transactions on VTVT: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 18, 24 | Paul J SekhriPres, CEO and Exec Chairperson | BUY | 1.8K | $16.96 | $31K |
| Nov 15, 24 | Paul J SekhriPres, CEO and Exec Chairperson | BUY | 1.8K | $16.88 | $30K |
| Nov 29, 22 | John A FryDirector | BUY | 40.5K | $0.83 | $34K |
| Nov 28, 22 | John A FryDirector | BUY | 20.5K | $0.83 | $17K |
| Dec 20, 21 | Ronald O PerelmanTenPercentOwner | SELL | 87.0K | $1.15 | $100K |
Over the past 12 months, insiders at vTv Therapeutics Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on VTVT, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market VTVT insider purchase in our data was $34K by John A Fry, Director, filed on Nov 29, 22.
0 different insiders at vTv Therapeutics Inc. filed open-market SEC Form 4 transactions on VTVT over the last 12 months.
InsiderTape plots every VTVT insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every vTv Therapeutics Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →